Shopping Cart
Remove All
Your shopping cart is currently empty
CX 717 is a positive allosteric modulator of the AMPA receptor with antidepressant-like effects and potential use in adult attention deficit hyperactivity disorder (ADHD) research [1] [2].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | $38 | In Stock | In Stock | |
| 25 mg | $77 | In Stock | In Stock | |
| 50 mg | $119 | In Stock | In Stock | |
| 100 mg | $197 | - | In Stock | |
| 200 mg | $293 | - | In Stock |
| Description | CX 717 is a positive allosteric modulator of the AMPA receptor with antidepressant-like effects and potential use in adult attention deficit hyperactivity disorder (ADHD) research [1] [2]. |
| In vivo | CX 717 (CX717; 20 mg/kg) exhibits a rapid (30 min) but short-lasting (up to 24 h) antidepressant-like effect in the forced swim test. It swiftly increases brain-derived neurotrophic factor (BDNF) within 1 hour and sustains elevated p11 levels for up to 6 hours [2]. When infused intra-cortically at 85 mM, CX 717 enhances the efflux of noradrenaline, dopamine, and serotonin without altering glutamate levels [2]. Male Sprague-Dawley rats (280-350 g) received a dosage of 20 mg/kg (at 1 mL/kg) via intraperitoneal injection. Results indicated that CX 717 provoked antidepressant-like effects without changing extracellular noradrenaline (NA), dopamine (DA), serotonin (5-HT), and glutamate levels in the medial prefrontal cortex (mPFC) [2]. |
| Molecular Weight | 233.23 |
| Formula | C11H11N3O3 |
| Cas No. | 867276-98-0 |
| Smiles | O=C(N1CCOCC1)c1ccc2nonc2c1 |
| Relative Density. | no data available |
| Color | White |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 45 mg/mL (193 mM), Sonication and heating to 60℃ are recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (8.58 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.